Home › Funds › ESSEX INVESTMENT MANAGEMENT CO LLC › PGEN
ESSEX INVESTMENT MANAGEMENT CO LLC position in PGEN
PRECIGEN INC · Health Care
ESSEX INVESTMENT MANAGEMENT CO LLC reported holding 683,419 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 0.87% of its reported portfolio and ranking #40 among its reported holdings. ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed PGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How ESSEX INVESTMENT MANAGEMENT CO LLC's PGEN position evolved
ESSEX INVESTMENT MANAGEMENT CO LLC first disclosed a stake in PGEN in Q2 2026 at 706,294 shares (US$4.0M). The position peaked in Q3 2026 at 683,419 shares, worth US$5.9M. Across 2 filings, ESSEX INVESTMENT MANAGEMENT CO LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 683,419 shares valued at US$5.9M — a reduction of -22,875 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 706.29K | $4.03M | New |
| Q3 2026 | 683.42K | $5.85M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PGEN and 13F data
PGEN (PRECIGEN INC) is a Health Care company. 58 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$108.5M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PGEN
- Patient Capital Management, LLC 19.04M sh · $108.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 6.42M sh · $36.58M · Q2 2026
- Boxer Capital Management, LLC 5.15M sh · $29.36M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 4.03M sh · $22.98M · Q2 2026
- Diametric Capital, LP 1.41M sh · $8.05M · Q2 2026
- LexAurum Advisors, LLC 633.53K sh · $5.42M · Q3 2026
- GMT CAPITAL CORP 668.83K sh · $3.81M · Q2 2026
- Lansing Street Advisors 495.42K sh · $2.82M · Q2 2026
- Occam Crest Management LP 35.50K sh · $2.49M · Q2 2026
More on ESSEX INVESTMENT MANAGEMENT CO LLC
FAQ
How long has ESSEX INVESTMENT MANAGEMENT CO LLC held PGEN?
ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed PGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in PGEN?
As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 683.42K shares of PGEN (PRECIGEN INC), valued at $5.85M, representing 0.87% of its reported portfolio and ranking #40.
Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling PGEN?
In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC reduced its position in PGEN. The position peaked in Q3 2026 at 683.42K shares.
Which other funds hold PGEN?
Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.